Company record
Imprimis NJOF, LLC
0 FDA warning letters since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about Imprimis NJOF, LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jan 14 | Class II | Imprimis NJOF, LLC Drug |
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06. Presence of particulate matter - Glass like particles. FDA notice D-0251-2026 |
| Jan 14 | Class II | Imprimis NJOF, LLC Drug |
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01. Presence of particulate matter - Glass like particles. FDA notice D-0250-2026 |
| Jan 14 | Class II | Imprimis NJOF, LLC Drug |
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1 Presence of particulate matter - Glass like particles. FDA notice D-0249-2026 |
| Nov 26, 2025 | Class III | Imprimis NJOF, LLC Drug |
Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852,… Subpotent Drug FDA notice D-0157-2026 |